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intake (50 patients with adenosine, and 24 patients with 
regadenoson). T1 mapping was performed using a modified 
look-locker inversion recovery sequence. T1 reactivity was 
determined by subtracting  T1rest from  T1stress.  T1rest,  T1stress, 
and T1 reactivity in patients referred for regadenoson perfu-
sion CMR were not significantly different when comparing 
patients with <4 h coffee intake and patients who reported 
no coffee intake (976 ± 4 ms, 1019 ± 48 ms, and 4.4 ± 3.2% 
vs 971 ± 33  ms, 1023 ± 43  ms, and 5.4 ± 2.4%) (p = 0.70, 
0.79, and 0.40), and similar to values in patients without 
coffee intake undergoing adenosine CMR. In patients with 
<4 h coffee intake,  T1stress, and T1 reactivity were signifi-
cantly lower for adenosine (898 ± 51 ms, and −7.8 ± 5.0%) 
compared to regadenoson perfusion CMR (p < 0.001). Cof-
fee intake <4 h prior to regadenoson perfusion CMR has 
no effect on stress-induced hyperemia as measured with T1 
mapping.
Keywords Coronary artery disease (CAD) · Cardiac 
magnetic resonance (CMR) · T1 mapping
Abbreviations
CAD  Coronary artery disease
COPD  Chronic obstructive pulmonary disease
HR  Heart rate
HRR  Heart rate response
LGE  Late gadolinium enhancement
MOLLI  Modified look-locker inversion recovery
CMR  Cardiac magnetic resonance
PET  Positron emitting tomography
PSIR  Phase sensitive inversion recovery
RR  Blood pressure
SPECT  Single photon emitting tomography
Abstract The antagonistic effects of caffeine on adeno-
sine receptors are a possible cause of false-negative stress 
perfusion imaging. The purpose of this study was to deter-
mine the effects of coffee intake <4 h prior to stress per-
fusion cardiac magnetic resonance imaging (CMR) in 
regadenoson- versus adenosine-induced hyperemia as 
measured with T1-mapping. 98 consecutive patients with 
suspected coronary artery disease referred for either adeno-
sine or regadenoson perfusion CMR were included in this 
analysis. Twenty-four patients reported coffee consump-
tion <4 h before CMR (15 patients with adenosine, and 9 
patients with regadenoson); 74 patients reported no coffee 
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Introduction
Stress perfusion cardiac magnetic resonance imaging (CMR) 
is an excellent technique to diagnose myocardial ischemia 
with high diagnostic accuracy [1, 2]. The most widely used 
stress agent in stress perfusion CMR is adenosine. This vaso-
dilator is an unselective agonist for at least four of the adeno-
sine receptor subtypes and results in coronary hyperemia 
due to the binding with cardiac  A2A receptors [3, 4]. Another 
vasodilator agent that can be used in stress CMR is regadeno-
son. Because this selective  A2A agonist does not bind to the 
other adenosine receptor subtypes, this stressor can be used 
in patients with chronic obstructive lung disease [5–7]. A par-
ticular concern when using vasodilator perfusion CMR in the 
evaluation of myocardial ischemia are false negative results 
[8]. They are reported to occur in around 5–15% of cases [2, 
9, 10], and results from a substudy of the CE-MARC study 
suggest that over one-third of false negative studies may be 
related to drug interactions and subsequent insufficient stress 
[8]. Caffeine plays an important role in stress perfusion imag-
ing because of his antagonistic properties to coronary hyper-
emia. As caffeine binds to the same receptors, intake of cof-
fee or other caffeine containing products shortly before stress 
CMR may interfere with the hyperaemic and hemodynamic 
response during both adenosine and regadenoson stress 
CMR.
In CMR, native (non-contrast) T1 mapping can be used for 
the quantification of myocardial water content, as a derivative 
measure of myocardial blood volume (MBV) [11]. This prop-
erty of native T1 mapping enables the quantitative assessment 
of changes in myocardial water content during stress perfu-
sion CMR. The difference between stress and rest T1 values 
can differentiate between ischemic, infarcted, remote, and 
normal myocardium [12]. Recently, we showed that T1 map-
ping can also identify patients who are stressed inadequately 
during adenosine perfusion CMR. Coffee intake less than 4 h 
prior to the examination caused an inversion of T1 reactiv-
ity during adenosine perfusion CMR [13]. So far no studies 
analyzed the effect of caffeine intake on regadenoson perfu-
sion CMR. We hypothesize that regadenoson perfusion CMR 
is less effected by the antagonistic effect of caffeine due to the 
highly selective  A2A agonistic properties of regadenoson.
The purpose of this study was to determine the effects of 
coffee intake less the 4 h prior to stress perfusion CMR in 
regadenoson- versus adenosine-induced hyperemia.
Materials and methods
Patient selection
The institutional review board approved this study. 
All patients provided written informed consent before 
enrolment. Between August 2015 and March 2016, 260 
consecutive patients with suspected coronary artery dis-
ease referred for stress CMR with either adenosine or, 
in case of contra-indications to adenosine (e.g., COPD), 
regadenoson were screened. All patients received prior, 
routine instructions, sent to their home, to avoid poten-
tial adenosine or regadenoson agonists for at least 24  h 
before CMR (e.g., coffee, tea, or chocolate and cacao). 
In addition, all anti-anginal medication (including beta-
blockers) was discontinued 4 days prior to the examina-
tion. Patients on dypiridamole and unable to discontinue 
this drug were excluded. At arrival in the MRI facility 
patients were systematically interviewed on the recent 
intake of coffee and other caffeine containing substances. 
Visual assessment of the first pass perfusion images, 
motion artefacts, and Late Gadolinium enhancement 
images was performed. Patients were excluded from 
further analysis when ischemia, infarction, substantial 
motion artefacts, or technical failures were present A 
flow chart of the inclusion/exclusion is shown in Fig. 1. 
Results on rest-stress T1-mapping of the study population 
undergoing adenosine perfusion CMR was previously 
reported [13].
CMR protocol
A 1.5T MRI system (Magnetom Avanto; Siemens Health-
care, Erlangen, Germany) was used in all patients. After 




General CMR contraindications (n=2)
Caffeine intake 8-24 hours before CMR (n=10)
Underlying cardiomyopathy (n=24)






Fig. 1  Flowchart of the inclusion and exclusion of patients. Motion 
artefacts were mainly due to incapability of patients with COPD to 
perform adequate breath holds
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look-locker inversion recovery (MOLLI) based T1 map-
ping sequence (WIP780B) was performed at rest and in 
stress. A 5(3)3 sampling scheme of the heart was per-
formed, including 8 images in 11 heartbeats. For the 
MOLLI acquisition an initial Inversion time of 110  ms 
was used with an 80  ms increment. A pixel-wise T1 
map of the myocardium was acquired in a mid-ventric-
ular short-axis view with inline motion correction. The 
images were generated using a single-shot steady-state 
free-precession readout. Typical parameters were: field of 
view, 300 × 256 mm²; slice thickness 8 mm; base resolu-
tion 192; in plane spatial resolution, 1.4 × 1.4 mm²; band-
width, 1085  Hz/pixel; flip angle, 35° and parallel imag-
ing acceleration factor, 2. Native T1 maps were acquired 
at rest, and 60  s after intravenous regadenoson injec-
tion (bolus of 400  µg, injected over 10  s). Next, stress-
only perfusion imaging was performed as previously 
described [14]. In brief, a nonselective saturation recov-
ery perfusion sequence was started during the first pass 
of 0.1 mmol/kg gadopentetate dimeglumine injected at a 
flow rate of 5 ml/s, directly after the stress T1 map. Equal 
position of the short-axis slices was used in T1 mapping 
and perfusion imaging. An overview of the CMR proto-
col is shown in Fig. 2. As a proof of concept we present 
two cases in which ischemia assessment was still possible 
despite of coffee intake prior to the regadenson perfusion 
CMR examination as shown in Fig. 3.
Image analysis
T1 maps were independently analysed by two radiolo-
gists (DK, TK) with more than 10 years of experience in 
CMR. Both readers performed the analysis in a random 
order and were blinded to the patient data. The quantita-
tive measurements of the T1 relaxation times were per-
formed using commercially available mapping software 
(MASS analytical software, Medis, Leiden, The Nether-
lands). To avoid partial volume effects of the blood pool, 
all samples were in the core of the ROI, using conserva-
tive septal sampling [15]. For this study the perfusion and 
LGE series were not involved in the analysis (however, 
CMR examinations with signs of ischemia or infarction 
were at the beginning excluded).
Statistical analysis
Continuous values are presented as mean values with 
±standard deviation (SD). Categorical data are presented 
as percentages. Differences between two groups were 
assessed by using independent sample t test, and paired 
t test in case of paired data. One-way ANOVA was used 
to compare three or more groups. Statistical significance 
was defined as a p-value < 0.05. Statistical analyses were 
performed by using SPSS statistics 23 (IBM corporation, 
USA).
Results
The total study population consisted of 98 consecutive 
patients, aged 65 ± 11  years, with 49% men. 24 patients 
reported consuming coffee <4 h (15 patients with aden-
osine, and 9 patients with regadenoson) before stress 
perfusion CMR and 74 patients who reported no coffee 
intake (50 patients with adenosine perfusion CMR, and 
24 patients with regadenoson perfusion CMR). Patient 
characteristics and hemodynamics are shown in Table 1.
T1 mapping in patients without self-reported coffee 
intake
T1rest,  T1stress, and T1 reactivity values are shown in 
Table 2. In patients who reported no coffee intake  T1rest, 
 T1stress, and T1 reactivity were not significantly different 
when comparing the control adenosine group with the 
control regadenoson group (at p = 0.48, 0.62, and 0.08, 
respectively).
Fig. 2  Overview of the cardiac CMR protocol. Cine function imag-
ing is followed by native T1 mapping during rest and stress, 40  s 
stress perfusion imaging, and Late Gadolinium Enhancement images. 
Stressor agent was either adenosine (continuous infusion for 3  min 
before stress perfusion acquisition) or regadenoson (single bolus 
before stress perfusion acquisition)




Fig. 3  Myocardial ischemia assessment in two patients who con-
sumed coffee several hours before Regadenoson perfusion CMR 
study. Top row 84 year-old women who had coffee < 4 h before the 
stress study (T1 reactivity of 4.6%). Native T1 mapping (a), peak per-
fusion (b), and late perfusion (c) images are shown. The perfusion 
image showed a transmural perfusion defect in the inferior wall in 
multiple segments, consistent with myocardial ischemia. This perfu-
sion defect was caused by a significant stenosis in the right coronary 
artery, for which the patient received PCI treatment. Bottom row 75 
year-old men who had coffee 2 h before the stress study (T1 reactivity 
of 4.2%). Native T1 mapping (d), peak perfusion (e), and late perfu-
sion (f) images are shown. The perfusion study showed one segmen-
tal perfusion defect in the lateral wall. This patient was treated medi-
cally. 
Table 1  Patient characteristics and hemodynamics
† HRR—% change in HR from rest to stress
†† Systolic RR response—% change in systolic RR
‡ Diastolic RR response—% change in diastolic RR. Results are presented as mean ± standard deviation or n (%)












Age (years) 65 ± 11 67 ± 11 66 ± 11 67 ± 11 59 ± 11
Male 16 (49) 22 (44) 11 (46) 8 (53) 5 (56)
Systolic RR rest (mm Hg) 148 ± 20 146 ± 28 147 ± 19 144 ± 20 151 ± 21
Systolic RR stress (mm Hg) 135 ± 20 142 ± 23 133 ± 19 139 ± 15 139 ± 23
Diastolic RR rest (mm Hg) 88 ± 12 85 ± 19 89 ± 12 83 ± 9 85 ± 9
Diastolic RR stress (mm Hg) 81 ± 12 80 ± 10 82 ± 11 79 ± 7 79 ± 14
HR rest (bpm) 78 ± 18 76 ± 15 82 ± 18 70 ± 7 67 ± 12
HR stress (bpm) 100 ± 20 87 ± 14 107 ± 18 81 ± 10 84 ± 12
HRR† (%) 21 16 32 16 26
Systolic RR  response†† (%) −5 ± 10 −2 ± 12 −9 ± 7 −3 ± 7 −8 ± 5
Diastolic RR  response‡ (%) −5 ± 10 −4 ± 11 −7 ± 9 −4 ± 8 −8 ± 10
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T1 mapping in patients undergoing adenosine perfusion 
CMR
T1rest in adenosine perfusion CMR was not significantly 
different when comparing patients with coffee intake <4 h 
prior to the examination with patients who reported no cof-
fee intake (at p = 0.83). In contrast,  T1stress, and T1 reactiv-
ity in patients with <4  h coffee intake were significantly 
lower as compared to patients without self-reported coffee 
intake (both at p < 0.001).
T1 mapping in patients undergoing regadenoson 
perfusion CMR
T1rest,  T1stress, and T1 reactivity in patients undergoing 
regadenoson perfusion CMR were similar for patients with 
coffee intake <4  h prior to the examination and patients 
who reported no coffee intake (at p = 0.70, 0.79, and 0.40, 
respectively).
T1 reactivity mapping in patients with coffee intake 
<4 h prior to the examination
T1rest in patients with self-reported coffee intake was simi-
lar for patients undergoing adenosine perfusion CMR 
and patients undergoing regadenoson perfusion CMR at 
p = 0.96. However,  T1stress, and T1 reactivity were signifi-
cantly lower in patients with <4 h coffee intake undergoing 
adenosine perfusion CMR when compared to patients with 
self-reported coffee intake undergoing regadenoson perfu-
sion CMR both at p < 0.001.
Heart rate and blood pressure
In the group of patients who reported no coffee intake 
(controls), resting heart rate  (HRrest) was not significantly 
different when comparing adenosine perfusion CMR 
with regadenoson perfusion CMR (at p = 0.18). HR dur-
ing stress  (HRstress) was significantly lower in the control 
group of patients undergoing adenosine perfusion CMR as 
compared to the control group with regadenoson perfusion 
CMR (at p < 0.001). There was no significant difference in 
the diastolic blood pressure (RR) response when compar-
ing the adenosine control group with the regadenoson con-
trol group (at p = 0.37). The systolic RR response and Heart 
rate response (HRR) were significantly lower in the adeno-
sine control group as compared to the regadenoson control 
group (at p = 0.004, and p < 0.001).
There was no significant difference in  HRrest and  HRstress 
in patients who reported no coffee intake as compared to 
patients with coffee intake <4 h prior to the examination in 
the adenosine perfusion CMR group (at p = 0.16, p = 0.13). 
In the patients undergoing regadenoson perfusion CMR 
both  HRrest and  HRstress were significantly higher in patients 
without self-reported coffee intake when compared to the 
patients with coffee intake <4  h prior to the examination 
(at p = 0.03, and p = 0.002). The diastolic RR response, sys-
tolic RR response, and HRR in control patients undergoing 
adenosine perfusion CMR were not significantly different 
when compared to the diastolic and systolic RR response 
in patients with <4  h coffee intake at p = 0.96, 0.96, and 
0.95. The diastolic RR response, systolic RR response, and 
HRR in patients without self-reported coffee intake under-
going regadenoson perfusion CMR were also not signifi-
cantly different when compared to the diastolic and systolic 
RR response in patients with <4 h coffee intake at p = 0.81, 
0.69, and 0.299, respectively.
Discussion
Our study is the first to perform a direct comparison com-
parison of the effects of coffee intake prior to either aden-
osine or regadenoson stress perfusion CMR. To assess 
changes in myocardial blood volume, we determined native 
T1 values and we report that  T1stress and the T1 reactivity 
are not significantly affected by consumption of coffee in 
the hours prior to the stress perfusion CMR when regaden-
oson is used as stressor, in contrast to adenosine where cof-
fee intake causes a strong negative effect. In the patients 
without coffee intake both stress agents induced a compa-
rable increase in MBV as measured with T1 mapping and 
the ΔT1 values in these groups showed no significant dif-
ference with ΔT1 of the regadenoson caffeine <4 h group.
Table 2  Rest-Stress 
T1-mapping results
Results are presented as mean ± standard deviation







trol (n = 24)
Adenosine 





T1 rest (ms) 975 ± 38 977 ± 41 971 ± 33 975 ± 42 976 ± 34
T1 stress (ms) 1001 ± 61 1018 ± 40 1023 ± 43 898 ± 51 1019 ± 48
T1-reactivity (%) 2.7 ± 5.5 4.3 ± 2.8 5.4 ± 2.4 −7.8 ± 5.0 4.4 ± 3.2
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Previous research on the effects of caffeine ingestion on 
the response to vasodilator agents in stress perfusion imag-
ing is limited and the available evidence shows contradic-
tory results.
A study by Gaemperli et  al. showed that, in posi-
tron emission tomography (PET) imaging, ingestion of 
a 200 mg caffeine capsule 2 h prior to regadenoson stress 
perfusion imaging had no significant effect on the phar-
macological response as measured by the increase in myo-
cardial blood flow during stress [16]. However, in a myo-
cardial perfusion scintigraphy (MPS) study, there was a 
significant decrease in the number of segments with revers-
ible defect in case of caffeine intake as compared to the pla-
cebo group in patients undergoing regadenoson MPS [17].
A possible explanation for our findings is the selective 
and potent  A2A nature of regadenoson as compared to aden-
osine. Regadenoson already achieves maximal coronary 
hyperemia when only 25% of the  A2A receptors is occupied 
[16]. Adenosine is a less potent and unselective  A2A ago-
nist and thus potentially more sensitive to the competitive 
antagonistic properties of caffeine.
Secondly, a relatively high dose of caffeine (equivalent 
to 2–4 cups of coffee) was used in the regadenoson MPS 
study 90  min prior to the examination [17]. In our study 
serum caffeine measurement was not performed and 
patients did not received a fixed dose of caffeine. Coffee 
intake in our study was equivalent to 1–2 cups of coffee. As 
reported earlier, at lower concentrations caffeine clearance 
occurs through the principals of first-order elimination, 
however at higher dose zero-order elimination occurs [18, 
19]. The differences in behaviour of caffeine at low and 
high dose is the most likely explanation for the findings of 
the discussed studies.
Animal studies investigating the effects of increasing 
concentrations of caffeine have shown a dose dependent 
relationship between caffeine and hemodynamic effects 
such as lowering of heart rate in the first hours after caf-
feine ingestion [20, 21]. In our study, patients undergoing 
adenosine perfusion CMR, showed no difference in the 
hemodynamic response when comparing patients without 
self-reported coffee intake to the patients with self-reported 
coffee intake. For the patients with regadenoson perfusion 
CMR both  HRrest and  HRstress were significantly lower in 
the group with coffee intake prior to the examination. 
These results are in conjunction with a study by Bitar et al., 
who reported a blunted rise in heart rate but no significant 
difference in HRR when comparing patients with and with-
out caffeine ingestion [22]. The heart rate lowering effects 
of caffeine that we have observed in our study has been 
reported earlier [21, 23].
In our study the diastolic RR, systolic RR and HRR 
response in the patients undergoing regadenoson perfu-
sion CMR were not significantly different when comparing 
patients with and without self-reported coffee intake. The 
differences in the hemodynamic response to either adeno-
sine or regadenoson in combination with caffeine intake is 
possibly explained by interaction of the substances lead-
ing to a combination of altered sympathetic tone, variable 
chemoreceptor response, and vasodilatory effects [20].
Limitations
This study was performed in a small study population 
with only self-reported coffee intake, meant as a proof 
of concept. Serum caffeine measurements were not per-
formed and patients did not received a fixed dose of caf-
feine. We cannot exclude the possibility that a number of 
patients in our study has consumed other caffeine contain-
ing substances in the period before the examination. If so, 
this would have led to bias towards zero in the adenosine 
group, meaning that the measured effect that we found in 
our study is possibly an underestimation of the real effect 
of caffeine intake on hyperemia in adenosine perfusion 
CMR. Another limitation is the selection bias because only 
patients with contra-indications to adenosine, in this study 
COPD, received regadenoson as stressor. Due to the inabil-
ity of these patients to perform an adequate breath hold, the 
MOLLI sequence used in this study showed many studies 
with motion artefacts, which could have been overcome by 
using shorter independent heart rate T1 sequences.
Implications
Our study is the first to report on the effects of coffee intake 
prior to regadenoson perfusion CMR. We show that, in 
contrast to the negative effects during adenosine perfu-
sion CMR, coffee intake has no effect on the hyperaemic 
response to regadenoson, as indicated by the T1 reactivity 
mapping.
This finding may be important in clinical practice, 
because regadenoson can be used directly as an adequate 
alternative stressor in patients referred for adenosine stress 
CMR who inadvertently ingested coffee before the stress 
study, reducing the number of cancelled and rescheduled 
stress studies.
Furthermore T1 reactivity, as an imaging biomarker, 
can be used as a bench-mark for the assessment of stress 
adequacy during vasodilator perfusion CMR and should be 
reported in the results.
Conclusions
Coffee intake <4  h prior to regadenoson perfusion CMR 
appears to have no effect on stress induced hyperemia as 
measured with T1 mapping.
Int J Cardiovasc Imaging 
1 3
Acknowledgements This study was supported by a grant of Zon-
MW Innovative Medical Devices Initiative LSH 2014 (10-10400-98-
14017) and a grant of the Dutch Heart Foundation (CVON2015-17).
Compliance with ethical standards 
Conflict of interest M. Oudkerk has received an unrestricted educa-
tional grant from Rapiscan, Pharmacological Solutions on 27 Septem-
ber 2016 for research in coronary physiology.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted 
use, distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
 1. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, 
Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati 
A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, 
Schauerte P, Uva MS, Stefanini GG, Taggart DP, Torracca L, 
Valgimigli M, Wijns W, Witkowski A (2015) 2014 ESC/EACTS 
guidelines on myocardial revascularization. Rev Esp Cardiol 
68(2):144 (Engl Ed)
 2. Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huet-
tle K, Schönberg SO, Debl K, Strohm O, Ahlstrom H, Dill T, 
Hoebel N, Simor T (2012) Superior diagnostic performance of 
perfusion-cardiovascular magnetic resonance versus SPECT to 
detect coronary artery disease: the secondary endpoints of the 
multicenter multivendor MR-IMPACT II (magnetic resonance 
imaging for myocardial perfusion assessment in Coronary Artery 
Disease Trial). J Cardiovasc Magn Res 14:61–71
 3. Fredholm BB, Irenius E, Kull B (2001) Comparison of the 
potency of adenosine as an antagonist at human adenosine recep-
tors expressed in Chines hamster ovary cells. Biochem Pharma-
col 61:443–448
 4. Ribeiro J, Sebastastião AM (2010) Caffeine and adenosine. J 
Alzheimer’s Dis 20:S3–S15
 5. Trochu JN, Zhao G, Post H (2003) Selective A-2a receptor ago-
nist as a coronary vasodilatator in conscious dogs: potential for 
use in myocardial perfusion imaging. J Cardiovasc Pharmacol 
41:132–139
 6. Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo 
JA, Blackburn B, Mahmarian JJ (2005) Initial clinical experience 
with regadenoson, a novel selective A 2 A agonist for pharmaco-
logic stress single-photon emission computed tomography myo-
cardial perfusion imaging. J Am Coll Cardiol 46(11):2069–2075
 7. Johnson SG, Peters S (2010) Advances in pharmacologic 
stress agents: focus on regadenoson. J Nucl Med Technol 
38(3):163–171
 8. Plein S, Kidambi A, Sourbon S, Maredia N, Uddin A, Motwani 
M, Ripley DP, Herzog BA, Brown J, Nixon J, Everett C, Green-
wood JP (2013) Associated factors for a false negative cardio-
vascular magnetic resonance perfusion study: a CE-MARC sub-
study. J Cardiovasc Magn Reson 15(Suppl 1):P214
 9. Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, 
Nixon J et al (2016) Factors associated with false-negative cardi-
ovascular magnetic resonance perfusion studies: a clinical evalu-
ation of magnetic resonance imaging in coronary artery disease 
(CE-MARC) substudy. J Magn Reson Imaging 43(3):566–573
 10. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, 
Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson 
CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance 
and sin-gle-photon emission computed tomography for diagnosis 
of coronary heart disease (CE-MARC): a prospective trial. Lan-
cet 379(9814):453–460
 11. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson 
MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neu-
bauer S, Schulz-Menger J, Schelbert EB (2013) Myocardial T1 
mapping and extracellular volume quantification: a Society for 
Cardiovascular Magnetic Resonance (SCMR) and CMR Work-
ing Group of the European Society of Cardiology consensus 
statement. J Cardiovasc Magn Reson 15:92
 12. Liu A, Wijesurendra RS, Francis JM, Robson MD, Neubauer S, 
Piechnik SK, ferreira VM (2016) Adenosine stress and rest T1 
mapping can differentiate between ischemic, infarcted, remote, 
and normal myocardium without the need for gadolinium con-
trast agents. J Am Coll Cardiol 9:27–36
 13. Kuijpers D, Prakken NH, Vliegenthart R, van Dijkman PRM, van 
der Harst P, Oudkerk M (2016) Caffeine intake inverts the effect 
of adenosine on myocardial perfusion during stress as measured 
with T1 mapping. Int J Cardiovasc Imaging 32(10):1545–1553
 14. Lubbers DD, Rijlaarsdam-Hermsen D, Kuijpers D, Kerkhof M, 
Sijens PE, van Dijkman PRM, Oudkerk M (2012) Performance 
of adenosine “stress-only” perfusion MRI in patients without a 
history of myocardial infarction: a clinical outcome study. Int J 
Cardiovasc Imaging 28(1):109–115
 15. Child N, Yap ML, Dabir S, Rogers T, Suna G, Sandhu B, Hig-
gins DM, Mayr M, Nagel E, Puntmann VO (2015) T1 values 
by conservative septal post-processing approach are superior 
in relating to the interstitial myocardial fibrosis: findings from 
patients with severe aortic stenosis. J Cardiovasc Magn Reson 
17(S1):49
 16. Gaemperli O, Schepis T, Koepfli P, Siegrist PT, Fleischman S, 
Nguyen P, Kaufmann PA (2008) Interaction of caffeine with 
regadenoson-induced hyperemic myocardial blood flow as meas-
ured by positron emission tomography. A randomized, double-
blind, placebo-controlled crossover trial. J Am Coll Cardiol 
51(3):328–329
 17. Tejani FH, Thompson RC, Kristy R, Bukofzer S (2014) Effect 
of caffeine on SPECT myocardial perfusion imaging during 
regadenoson pharmacologis stress: a prospective, randomized, 
multicenter study. Int J Cardiovasc Imaging 30:979–989
 18. Cheng WS, Murphy TL, Smith MT, Cooksley WG, Halliday JW, 
Powell LW (1990) Dose-dependent pharmacokinetics of caffeine 
in humans: relevance as a test of quantitative liver function. Clin 
Pharmacol Ther 47(4):516–524
 19. Reyes E (2016) Caffeine does not significantly reduce the sen-
sitivity of vasodilator stress MPI: Rebuttal. J Nucl Cardiol 
23(3):604
 20. Yang JN, Tiseluis C, Daré E, Johansson B, Valen G, Fredholm 
BB (2007) Sex differences in mouse heart rate and body tem-
perature and in their regulation by adenosine A 1 receptors. Acta 
Physiol 190:63–75
 21. Fredholm BB, Yang J, Wang Y (2016) Low, but not high, dose 
cafeine is a readily available probe for adenosine actions. Mol 
Aspects Med 1–6. doi:10.1016/j.mam.2016.11.011
 22. Bitar A, Mastouri R, Kreutz RP (2015) Caffeine consumption 
and heart rate and pressure response to regadenoson. PLoS ONE. 
doi:10.1371/journal.pone.0130487
 23. Bichler A, Swenson A, Harris MA (2006) A combination of caf-
feine and taurine has no effect on short term memory but induces 
changes in heart rate and mean arterial blood pressure. Amino 
Acids 31(4):471–476
